PRESS RELEASES

PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary ERYTECH to Host First Quarter 2018 Conference Call and Business Update
LYON, France , May 09, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its 2018 first
View HTML
Toggle Summary Erytech: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital – April 30, 2018
Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France --(BUSINESS WIRE)--May 3, 2018-- Regulatory News : Erytech (Euronext: ERYP- Nasdaq: ERYP): Listing markets: Euronext Paris from Euronext (Market segment B - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq
View HTML
Toggle Summary Erytech: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital – April 30, 2018
Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France --(BUSINESS WIRE)--May 3, 2018-- Regulatory News : Erytech (Euronext: ERYP- Nasdaq: ERYP): Listing markets: Euronext Paris from Euronext (Market segment B - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq
View HTML
Toggle Summary ERYTECH Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-F
LYON, France --(BUSINESS WIRE)--Apr. 24, 2018-- Regulatory News : ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), the clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases based on its proprietary ERYCAPS platform,
View HTML
Toggle Summary ERYTECH Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-F
LYON, France --(BUSINESS WIRE)--Apr. 24, 2018-- Regulatory News : ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), the clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases based on its proprietary ERYCAPS platform,
View HTML
Toggle Summary Erytech: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital – March 31, 2018
Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France --(BUSINESS WIRE)--Apr. 16, 2018-- Regulatory News : Erytech (Euronext: ERYP- Nasdaq: ERYP): Listing markets: Euronext Paris from Euronext (Market segment B - ISIN Code: FR0011471135- Symbol : ERYP) & Nasdaq
View HTML
Toggle Summary Erytech: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital – March 31, 2018
Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France --(BUSINESS WIRE)--Apr. 16, 2018-- Regulatory News : Erytech (Euronext: ERYP- Nasdaq: ERYP): Listing markets: Euronext Paris from Euronext (Market segment B - ISIN Code: FR0011471135- Symbol : ERYP) & Nasdaq
View HTML
Toggle Summary ERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018
LYON, France --(BUSINESS WIRE)--Apr. 12, 2018-- Regulatory News : ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will
View HTML
Toggle Summary ERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018
LYON, France --(BUSINESS WIRE)--Apr. 12, 2018-- Regulatory News : ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will
View HTML
Toggle Summary ERYTECH to Webcast Presentation at the Cowen and Company 38th Annual Healthcare Conference
LYON, France --(BUSINESS WIRE)--Mar. 13, 2018-- Regulatory News: ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Chief Executive
View HTML
Top